S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 AI Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Did You Get Your Free Bitcoin Yet? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Options trading has suddenly become more reliable. (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 AI Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Did You Get Your Free Bitcoin Yet? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Options trading has suddenly become more reliable. (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 AI Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Did You Get Your Free Bitcoin Yet? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Options trading has suddenly become more reliable. (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Top 5 AI Stocks to Buy for 2024 (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Did You Get Your Free Bitcoin Yet? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Options trading has suddenly become more reliable. (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Free Trial

Fulgent Genetics (FLGT) Earnings Date, Estimates & Call Transcripts

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)
Free FLGT Stock Alerts
$20.09
-0.63 (-3.04%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 3
Before Market Opens
Confirmed
Actual EPS
(Feb. 28)
-$0.02 Beat By $0.61
Consensus EPS
(Feb. 28)
-$0.63
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

FLGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FLGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulgent Genetics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.04) EPS
Next Year EPS Consensus Estimate: ($1.66) EPS

FLGT Earnings Date and Information

Fulgent Genetics last announced its earnings data on February 28th, 2024. The reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.63) by $0.61. The business earned $70.51 million during the quarter, compared to analyst estimates of $67.14 million. Fulgent Genetics has generated ($5.64) earnings per share over the last year (($5.64) diluted earnings per share). Earnings for Fulgent Genetics are expected to grow in the coming year, from ($2.04) to ($1.66) per share. Fulgent Genetics has confirmed that its next quarterly earnings report will be published on Friday, May 3rd, 2024. Fulgent Genetics will be holding an earnings conference call on Friday, May 3rd at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Fulgent Genetics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/3/2024
Confirmed)		-------  
2/28/2024Q4 2023($0.63)($0.02)+$0.61$4.26$67.14 million$70.51 million
11/3/2023Q3 2023($0.32)($0.39)($0.07)($0.42)$64.42 million$84.70 million    
8/4/2023Q2 2023($0.59)($0.33)+$0.26($0.28)$62.68 million$67.85 million
5/5/2023Q1 2023($0.68)($0.47)+$0.21($0.42)$61.95 million$66.17 million
2/28/2023Q4 2022($0.78)($0.71)+$0.07($0.62)$59.44 million$67.70 million
11/7/2022Q3 2022($0.02)$0.11+$0.13$0.16$103.70 million$105.66 million    
8/4/2022Q2 2022$0.59$0.59-$0.81$122.70 million$125.30 million    
5/3/2022Q1 2022$4.32$4.93+$0.61$4.93$300.50 million$320.30 million    
2/23/2022Q4 2021$2.66$3.34+$0.68$3.34$191.10 million$251.67 million    
11/9/2021Q3 2021$1.30$3.93+$2.63$3.93$264.00 million$227.87 million
8/9/2021Q2 2021$2.54$2.47($0.07)$2.35$197.34 million$153.60 million    
5/6/2021Q1 2021$5.95$6.59+$0.64$6.50$326.46 million$359.43 million  

Fulgent Genetics Earnings - Frequently Asked Questions

When is Fulgent Genetics's earnings date?

Fulgent Genetics has confirmed that its next quarterly earnings data will be published on Friday, May 3rd, 2024. Learn more on FLGT's earnings history.

Did Fulgent Genetics beat their earnings estimates last quarter?

In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.61. Learn more on analysts' earnings estimate vs. FLGT's actual earnings.

How much revenue does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $289.21 million.

How much profit does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of -$167.82 million. FLGT has generated -$5.64 earnings per share over the last four quarters.

What is Fulgent Genetics's EPS forecast for next year?

Fulgent Genetics's earnings are expected to grow from ($2.04) per share to ($1.66) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:FLGT) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
You won't believe what Citigroup just did to it's depositors
American Alternative
AI healthcare stock poised for 36,996% growth?
Behind the Markets
Biden out June 13; Kamala won’t replace him?
Paradigm Press